[1] M. Abadi, A. Agarwal, P. Barham, E. Brevdo, Z. Chen, C. Citro, et al. (2016). TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems. Available at: http://arxiv.org/abs/1603.04467 [Accessed November 22, 2019].
[2] A. Abdelaziz, H. Spahn-Langguth, K.-W. Schramm, I.V. Tetko, Consensus modeling for HTS assays using in silico descriptors calculates the best balanced accuracy in Tox21 challenge, Front. Environ. Sci. 4 (2016) 2, https://doi.org/10.3389/fenvs.2016.00002.
[3] D. Alberga, D. Trisciuzzi, K. Mansouri, G.F. Mangiatordi, O. Nicolotti, Prediction of acute oral systemic toxicity using a multifingerprint similarity approach, Toxicol. Sci. 167 (2018) 484–495, https://doi.org/10.1093/toxsci/kfy255.
[4] B.N. Ames, J. McCann, E. Yamasaki, Methods for detecting carcinogens and mu- tagens with the salmonella/mammalian-microsome mutagenicity test, Mutat. Res. Mutagen. Relat. Subj. 31 (1975) 347–363, https://doi.org/10.1016/0165-1161(75) 90046-1.
[5] P. Anastas, K. Teichman, E.C. Hubal, Ensuring the safety of chemicals, J. Expo. Sci. Environ. Epidemiol. 20 (2010) 395–396, https://doi.org/10.1038/jes.2010.28.
[6] D. Ballabio, F. Grisoni, V. Consonni, R. Todeschini, Integrated QSAR models to predict acute oral systemic toxicity, Mol. Inform. 38 (2019) 1800124, https://doi. org/10.1002/minf.201800124.
[7] L. Breiman, Random forests, Mach. Learn. 45 (2001) 5–32, https://doi.org/10. 1023/A:1010933404324.
[8] J. Brown, Adaptive mining and model building of medicinal chemistry data with a multi-metric perspective, Future Med. Chem. 10 (2018) 1885–1887, https://doi. org/10.4155/fmc-2018-0188.
[9] J.B. Brown, Classifiers and their metrics quantified, Mol. Inform. 37 (2018), https:// doi.org/10.1002/minf.201700127.
[10] C.M. Fonseca, C.M. Fonseca, P.J. Fleming (1993). Genetic Algorithms for Multiobjective Optimization: Formulation, Discussion and Generalization. Available at: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.48.9077 [Accessed May 1, 2020].
[11] D. Gadaleta, K. Vuković, C. Toma, G.J. Lavado, A.L. Karmaus, K. Mansouri, et al., SAR and QSAR modeling of a large collection of LD50 rat acute oral toxicity data, J. Cheminform. 11 (2019) 58, https://doi.org/10.1186/s13321-019-0383-2.
[12] R. Huang, M. Xia, Editorial: Tox21 challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental toxicants and drugs, Front. Environ. Sci. 5 (2017) 3, https://doi.org/10.3389/fenvs. 2017.00003.
[13] D. Kirkland, M. Aardema, L. Henderson, L. Müller, Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity, Mutat. Res. Toxicol. Environ. Mutagen. 584 (2005) 1–256, https://doi.org/10.1016/J. MRGENTOX.2005.02.004.
[14] D. Kirkland, S. Pfuhler, D. Tweats, M. Aardema, R. Corvi, F. Darroudi, et al., How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop, Mutat. Res. Toxicol. Environ. Mutagen. 628 (2007) 31–55, https://doi.org/10.1016/J. MRGENTOX.2006.11.008.
[15] N.C. Kleinstreuer, A.L. Karmaus, K. Mansouri, D.G. Allen, J.M. Fitzpatrick, G. Patlewicz, Predictive models for acute oral systemic toxicity: a workshop to bridge the gap from research to regulation, Comput. Toxicol. (2018) 21–24, https://doi.org/10.1016/j.comtox.2018.08.002.
[16] T. Lang, F. Flachsenberg, U. von Luxburg, M. Rarey, Feasibility of active machine learning for multiclass compound classification, J. Chem. Inf. Model. 56 (2016) 12–20, https://doi.org/10.1021/acs.jcim.5b00332.
[17] J.C.D. Lopes, F.M. Dos Santos, A. Martins-José, K. Augustyns, H. De Winter, The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability, J. Cheminform. 9 (2017) 7, https://doi.org/10.1186/s13321-016-0189-4.
[18] K. Mansouri, J. Fitzpatrick, W. Casey, D. Allen, G. Patlewicz, A. Karmaus, et al., Developing predictive models for acute oral systemic toxicity: lessons learned from a global collaboration, CICSJ Bull. 37 (2019) 23, https://doi.org/10.11546/cicsj.37.23.
[19] B.W. Matthews, Comparison of the predicted and observed secondary structure of T4 phage lysozyme, BBA - Protein Struct. 405 (1975) 442–451, https://doi.org/10. 1016/0005-2795(75)90109-9.
[20] A. Mayr, G. Klambauer, T. Unterthiner, S. Hochreiter, DeepTox: toxicity prediction using deep learning, Front. Environ. Sci. 3 (2016) 80, https://doi.org/10.3389/ fenvs.2015.00080.
[21] N.S.H.N. Moorthy, S. Kumar, V. Poongavanam, Classification of carcinogenic and mutagenic properties using machine learning method, Comput. Toxicol. 3 (2017) 33–43, https://doi.org/10.1016/j.comtox.2017.07.002.
[22] A.W. Naik, J.D. Kangas, C.J. Langmead, R.F. Murphy, Efficient modeling and active learning discovery of biological responses, PLoS One 8 (2013) e83996, , https://doi. org/10.1371/journal.pone.0083996.
[23] F. Pedregosa, G. Varoquaux, A. Gramfort, V. Michel, B. Thirion, O. Grisel, et al., Scikit-learn: machine learning in Python, J. Mach. Learn. Res. 12 (2011) 2825–2830.
[24] A.H. Polash, T. Nakano, S. Takeda, J.B. Brown, Applicability domain of active learning in chemical probe identification: convergence in learning from non-spe- cific compounds and decision rule clarification, Molecules 24 (2019) 2716, https:// doi.org/10.3390/molecules24152716.
[25] A.H. Polash, N. Takumi, S. Takeda, J.B. Brown, Systematic approaches to build predictive models for rat oral toxicity, CICSJ Bull. 37 (2019) 12, https://doi.org/10. 11546/cicsj.37.12.
[26] C. Rakers, R.A. Najnin, A.H. Polash, S. Takeda, J.B. Brown, Chemogenomic active learning’s domain of applicability on small, sparse qHTS matrices: a study using cytochrome P450 and nuclear hormone receptor families, ChemMedChem 13 (2018) 511–521, https://doi.org/10.1002/cmdc.201700677.
[27] C. Rakers, R.A. Najnin, A.H. Polash, S. Takeda, J.B. Brown, Chemogenomic active learning’s domain of applicability on small, sparse qHTS matrices: a study using cytochrome P450 and nuclear hormone receptor families, ChemMedChem (2018), https://doi.org/10.1002/cmdc.201700677.
[28] D. Reker, J.B. Brown, Selection of informative examples in chemogenomic datasets, Methods Mol. Biol. (Humana Press, New York, NY) (2018) 369–410, https://doi. org/10.1007/978-1-4939-8639-2_13.
[29] D. Reker, G. Schneider, Active-learning strategies in computer-assisted drug dis- covery, Drug Discov. Today 20 (2015) 458–465, https://doi.org/10.1016/J. DRUDIS.2014.12.004.
[30] D. Reker, P. Schneider, G. Schneider, J. Brown, Active learning for computational chemogenomics, Future Med. Chem. 9 (2017) 381–402, https://doi.org/10.4155/fmc-2016-0197.
[31] I. Rusyn, G.P. Daston, Computational toxicology: realizing the promise of the toxicity testing in the 21st century, Environ. Health Perspect. 118 (2010) 1047–1050, https://doi.org/10.1289/ehp.1001925.
[32] G. Schneider, W. Neidhart, T. Giller, G. Schmid, “Scaffold-Hopping” by topological pharmacophore search: a contribution to virtual screening, Angew. Chem. Int. Ed. 38 (1999) 2894–2896.
[33] J. Shawe-Taylor, N. Cristianini (2004). Kernel methods for pattern analysis. Cambridge University Press Available at: https://books.google.co.jp/books?hl=en&lr=&id=9i0vg12lti4C&oi=fnd&pg=PR8&dq=Kernel+Methods+for+Pattern+Analysis&ots=olCFrl3F5R&sig=mzYdGeZt1vEmfL65QRbZlIzX_Uo#v=onepage &q=Kernel Methods for Pattern Analysis&f=false [Accessed June 30, 2019].
[34] S.J. Shukla, R. Huang, C.P. Austin, M. Xia, The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform, Drug Discov. Today 15 (2010) 997–1007, https://doi.org/10.1016/j.drudis.2010.07.007.
[35] K. Taylor, Ten years of REACH—an animal protection perspective, Altern. Lab. Anim. 46 (2018) 347–373, https://doi.org/10.1177/026119291804600610.
[36] O. Tcheremenskaia, C.L. Battistelli, A. Giuliani, R. Benigni, C. Bossa, In silico ap- proaches for prediction of genotoxic and carcinogenic potential of cosmetic in- gredients, Comput. Toxicol. 11 (2019) 91–100, https://doi.org/10.1016/j.comtox.2019.03.005.
[37] R.R. Tice, C.P. Austin, R.J. Kavlock, J.R. Bucher, Improving the human hazard characterization of chemicals: a Tox21 update, Environ. Health Perspect. 121 (2013) 756–765, https://doi.org/10.1289/ehp.1205784.
[38] Y. Uesawa, Rigorous selection of random forest models for identifying compounds that activate toxicity-related pathways, Front. Environ. Sci. 4 (2016) 9, https://doi. org/10.3389/fenvs.2016.00009.
[39] M.K. Warmuth, J. Liao, G. Rätsch, M. Mathieson, S. Putta, C. Lemmen, Active learning with support vector machines in the drug discovery process, J. Chem. Inf. Comput. Sci. (2003) 667–673, https://doi.org/10.1021/ci025620t.
[40] A.M. Wassermann, M. Wawer, J. Bajorath, Activity landscape representations for structure-activity relationship analysis, J. Med. Chem. 53 (2010) 8209–8223, https://doi.org/10.1021/jm100933w.
[41] M. Zaslavskiy, S. Jégou, E.W. Tramel, G. Wainrib, ToxicBlend: virtual screening of toxic compounds with ensemble predictors, Comput. Toxicol. 10 (2019) 81–88, https://doi.org/10.1016/j.comtox.2019.01.001.